课题基金 / 基金详情

Development of National Strategies for Implementing and Evaluating Evidence-Based Indicators for Benchmarking and Monitoring Asthma Care in Canada

Development of National Strategies for Implementing and Evaluating Evidence-Based Indicators for Benchmarking and Monitoring Asthma Care in Canada
制定实施和评估加拿大哮喘护理基准和监测循证指标的国家战略
批准号:
257823
负责人:
To Teresa
金额:
$1.81万
依托单位国家:
加拿大
项目类别:
Miscellaneous Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-02-01 至 2013-02-01

项目摘要

项目成果

To Teresa的其他基金

相关文献

中文摘要
翻译
哮喘是加拿大最常见的慢性呼吸道疾病,影响160万加拿大成年人和80万儿童和青少年。尽管哮喘的治疗和管理指南已经存在,但是在ASTH的质量上还是存在差异的
英文摘要
Asthma is the most common chronic respiratory disease in Canada affecting 1.6 million adult Canadians and 0.8 million children and teens. Even though guidelines exist for the treatment and management of asthma, there are differences in the quality of asth
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 1
  • 批准号:
    415521
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2019
  • 负责人:
    To Teresa
  • 依托单位: